Informationen:
Fehler:
ID
41215
Beschreibung
Proton Radiation for Lymphoma Involving Mediastinum; ODM derived from: https://clinicaltrials.gov/show/NCT01751412
Link
https://clinicaltrials.gov/show/NCT01751412
Stichworte
Versionen (1)
- 17.07.20 17.07.20 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
17. Juli 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Lymphoma NCT01751412
Eligibility Lymphoma NCT01751412
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Lymphoma NCT01751412
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Hodgkin Disease | Lymphoma, Non-Hodgkin
Item
histologically confirmed hodgkin lymphoma or non-hodgkin lymphoma
boolean
C0019829 (UMLS CUI [1])
C0024305 (UMLS CUI [2])
C0024305 (UMLS CUI [2])
Chemotherapy Completed Lymphoma Subtype | Therapeutic radiology procedure
Item
must complete standard chemotherapy appropriate for the histologic subtype of lymphoma and be able to start radiation therapy within 3-6 weeks of completing chemotherapy
boolean
C0392920 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0449560 (UMLS CUI [1,4])
C1522449 (UMLS CUI [2])
C0205197 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0449560 (UMLS CUI [1,4])
C1522449 (UMLS CUI [2])
Life Expectancy
Item
life expectancy of at least 12 months
boolean
C0023671 (UMLS CUI [1])
In complete remission Imaging Techniques | Partial response Imaging Techniques | Status post Chemotherapy
Item
must have achieved complete or partial response per appropriate imaging technique within 4 weeks of study entry following administration of chemotherapy
boolean
C0677874 (UMLS CUI [1,1])
C0079595 (UMLS CUI [1,2])
C1521726 (UMLS CUI [2,1])
C0079595 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
C0079595 (UMLS CUI [1,2])
C1521726 (UMLS CUI [2,1])
C0079595 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
HIV Seropositivity | Antiretroviral Therapy, Highly Active
Item
individuals with known history of hiv positivity must be on appropriate haart therapy
boolean
C0019699 (UMLS CUI [1])
C0887947 (UMLS CUI [2])
C0887947 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Prior Radiation Therapy Clinical target volume
Item
prior therapeutic radiation therapy > 200 cgy has been delivered to target volume
boolean
C0279134 (UMLS CUI [1,1])
C0454198 (UMLS CUI [1,2])
C0454198 (UMLS CUI [1,2])
Adverse effect of systemic agents | Recovery Lacking
Item
have not recovered from adverse events due to systemic agents administered more than 4 weeks earlier
boolean
C0261794 (UMLS CUI [1])
C2004454 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
C2004454 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
Comorbidity Uncontrolled
Item
uncontrolled intercurrent illness
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
Cancer Other | Exception Disease Free Duration | Exception Carcinoma in situ of uterine cervix | Exception Basal cell carcinoma | Exception Squamous cell carcinoma
Item
history of a different malignancy unless disease free for at least 2 years (cervical cancer in situ, basal or squamous cell carcinoma are acceptable)
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
C0449238 (UMLS CUI [2,4])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0007137 (UMLS CUI [5,2])
C1705847 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
C0449238 (UMLS CUI [2,4])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0007137 (UMLS CUI [5,2])
Investigational New Drugs
Item
receiving any other investigational agents
boolean
C0013230 (UMLS CUI [1])